Rezultati - James F. Trotter
- Showing 1 - 20 results of 38
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Outcomes of living donor liver transplantation for acute liver failure: The adult-to-adult living donor liver transplantation cohort study od Jeffrey Campsen, Andrés T. Blei, Jean C. Emond, James E. Everhart, Chris E. Freise, Anna S. Lok, Sammy Saab, Karen Wisniewski, James F. Trotter
Izdano 2008Artigo -
13
Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation od Marcelo Kugelmas, Purnima Spiegelman, Michael J. Osgood, David A. Young, James F. Trotter, Tracy Steinberg, Michael Wachs, Thomas H. Bak, Igal Kam, Gregory T. Everson
Izdano 2003Artigo -
14
Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: A multicenter cohort study od Jennifer C. Lai, Jacqueline G. O’Leary, James F. Trotter, Elizabeth C. Verna, Robert S. Brown, R. Todd Stravitz, Jeffrey D. Duman, Lisa Forman, Norah A. Terrault
Izdano 2012Artigo -
15
Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma od Christian Toso, James F. Trotter, Alice C. Wei, David L. Bigam, Shimul A. Shah, Joshua Lancaster, David Grant, Paul D. Greig, A. M. James Shapiro, Norman M. Kneteman
Izdano 2008Artigo -
16
Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates od Michael B. Fallon, Michael J. Krowka, Robert S. Brown, James F. Trotter, Steven Zacks, Kari E. Roberts, Vijay H. Shah, Neil Kaplowitz, Lisa Forman, Keith Wille, Steven M. Kawut
Izdano 2008Artigo -
17
A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy od James R. Burton, Jacqueline G. O’Leary, Elizabeth C. Verna, Varun Saxena, Jennifer L. Dodge, Richard T. Stravitz, Joshua Levitsky, James F. Trotter, Gregory T. Everson, Robert S. Brown, Norah A. Terrault
Izdano 2014Artigo -
18
Hepatitis C virus–infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men od Jennifer C. Lai, Elizabeth C. Verna, Robert S. Brown, Jacqueline G. O’Leary, James F. Trotter, Lisa Forman, Jeffrey D. Duman, Richard G. Foster, Todd R. Stravitz, Norah A. Terrault
Izdano 2011Artigo -
19
Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis od Mary E. Rinella, James F. Trotter, Manal F. Abdelmalek, Angelo H. Paredes, Margery A. Connelly, Mark Jaros, Lei Ling, Stephen J. Rossi, Alex M. DePaoli, Stephen A. Harrison
Izdano 2018Artigo -
20
Outcomes of donor evaluation in adult-to-adult living donor liver transplantation od James F. Trotter, Karen Wisniewski, Norah A. Terrault, James E. Everhart, Milan Kinkhabwala, Robert M. Weinrieb, Jeffrey H. Fair, Robert A. Fisher, Alan J. Koffron, Sammy Saab, Robert M. Merion
Izdano 2007Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Transplantation
Liver transplantation
Gastroenterology
Disease
Surgery
Liver disease
Cohort
Cirrhosis
Living donor liver transplantation
Pathology
Alternative medicine
Fatty liver
Intensive care medicine
Placebo
Fibrosis
Receptor
Steatohepatitis
Confidence interval
Donation
Immunosuppression
Physics
Primary sclerosing cholangitis
Tacrolimus
Agonist
Biology
Chronic liver disease
Clinical endpoint
Economic growth